4 He kills cells in the range of 10 gm from the site of 4 He generation. Therefore, it is theoretically possible to kill tumour cells without affecting adjacent healthy tissues, if '°B-compounds could be selectively delivered. BNCT has been applied to the treatment of malignant brain tumours (Sweet, 1951; Hatanaka, 1986) or melanoma (Mishima et al., 1983; by using '°B-compounds selectively taken up by tumour cells. It would be possible to apply BNCT for the treatment of various kinds of tumour, if sufficient amounts of '°B-compound could be delivered to the malignant cells by using monoclonal antibodies reactive to these cells. Takahashi et al. (1987) prepared anti-alpha foetoprotein monoclonal antibody conjugated with '0B-compound, and this produced cytotoxic effects on hepatoma cells in BNCT in vitro. However, in these experiments, antibody was shown to lose activity by the direct conjugation with '°B-compound.
Recently, liposomes have attracted attention as drug delivery systems (Bangham et al., 1965; Hashimoto et al., 1983; Konno et al., 1987; Tanaka, 1989) . It is possible to carry a large amount of '°B-compound in a liposome and, therefore, the liposome could deliver a large amount of the '°B-compound to a tumour cell, if it bears specific antibody against the cells on the surface.
In the present experiments, we prepared a liposome which contained '°B-compound and conjugated with a monoclonal antibody specific for the tumour cells on its surface. The immunoliposome was shown to deliver the '°B-compound to target tumour cells and inhibit tumour cell growth on thermal neutron irradiation in vitro.
Materials and methods
Target tumour cells Human pancreatic carcinoma cell line AsPC-1 (Chen, 1982) , producing carcinoembryonic antigen (CEA) (Gold & Freedman, 1965) (Laemmli, 1970) , purified CEA purchased from Kyouwa Hakkou Kougyo Co. Ltd. (Tokyo, Japan) and purified NCA (Kleist et al., 1972) kindly provided by Dr T. Sugiyama (Sapporo Medical College, Sapporo, Japan).
Immunocytological staining Reactivity of monoclonal anti-CEA, 2C-8, to various cell lines was examined by immunocytological technique described by Hsu et al. (1981) .
Briefly removed by washing with centrifugation at 20,000g. After treatment for 30 min at room temperature with 20 mM dithiothreitol to ensure the functional SH-group, the liposome was centrifuged at 20,000g. One ml of monoclonal antibody (0, 0.5, 1.0, 4.0 mg ml-') was incubated with an excess amount of SPDP for 30 min at room temperature. After removal of free SPDP by passage through a Sephadex G 25 column, the liposomes were suspended in the antibody solution. After incubation at 4°C overnight, the boronated immunoliposomes ('°B-Lip-MoAb) were washed by centrifugation at 20,000 g and suspended in I ml of 10 mM veronal buffer, pH 7.4, supplemented with 0.4% gelatin. An average diameter of the liposome was estimated to be 4.7 jt in dynamic light scattering analysis.
The liposome prepared was confirmed to be stable in serum as reported (Yeagle, 1985) , and boron was confirmed not to leak out of the liposome.
The determination of '"'B-compound concentration entrapped in liposomes
The amount of '°B-compound entrapped in liposomes was determined by a colorimetric method in the presence of curcumine (Ikeuchi & Amano, 1978) .
After oxidative degradation with potassium permanganate, boron was extracted with chloroform containing 2-ethyl-1, 3-hexanediol. Boron in the extract was converted into the boron-curcumine complex by adding an acetic acid solution of curcumine. Concentrated sulfuric acid was then added to the solution. After dilution with 95% (v/v) ethanol, the optimal absorbancy of the solution at 554 nm was measured by spectrophotometry.
Thermal neutron irradiation
AsPC-1 cells, 5 x I04 cells/culture, were incubated in a 96 well-microplate at 37°C in 5% CO2 in air for 8 h in the presence of immunoliposomes. After washing, the cells were irradiated with thermal neutron at the TRIGA-Il atomic reactor of Rikkyo University (Yokosuka, Japan). After irradiation, 0.25 ft Ci 3H TdR was added to each well and incubated for further 8 h. Then, the cells were harvested and the incorporation of thymidine was estimated in a liquid scintillation spectrometer.
The determination ofgamma-ray dose generated at the thermal neutron irradiation in the thermal column The gamma-ray generated during thermal neutron irradiation was measured using the ionisation chamber method (ICRU, 1964) "'B-compound were 178 ± 33 and 623 ± 80 lag ml-' liposome, respectively. Anti-CEA conjugated with liposome was estimated to be 734.0 ± 37 ytg ml-' liposome. Thus, the liposomes prepared with 100 mM and 250 mM "B compound were calculated to contain 5.0 x 10' and 1.3 x I04 "'B for each antibody, respectively. These results are shown as averages and standard error of the values obtained from five separate assays.
Growth inhibition of AsPC-J cells treated with immunoliposomes
In order to examine the effect of immunoliposomes on the growth of AsPC-1 cells, the cells were treated with liposomes prepared with 250 mM "'B-compound and 4 mg ml-l anti-CEA or anti-DNP. After washing to remove free liposomes, the cells were irradiated with various fluences of thermal neutrons and cultured in vitro. As shown in Figure 2 , AsPC-1 cells treated with the original suspension of immunoliposomes showed a reduction in growth by 50% at 1 x 1012 fluence or more of thermal neutrons. When AsPC-l cells were treated with immunoliposomes prepared with anti-DNP instead of anti-CEA, they grew as well as untreated cells. As shown in Figure 3 , the decrement in cell growth was dependent on the dose of the liposomes used, and liposomes without antibody or "'B-compound exerted little effect on cell growth.
These results indicate that immunoliposomes could carry "'B-compound to the target cells and exert toxic effects on thenm.
Effect of '°B-compound concentration in immunoliposomes on cytotoxicity In order to confirm the role of "'B-compound in the immunoliposome, the effect of '°B-compound concentration on the cytotoxicity of the liposome against AsPC-l cells was examined. Liposomes were prepared by using 25, 100, 250 mM or without '°B-compound and conjugated with 4 mg ml-' anti-CEA. These immunoliposomes were examined for their cytotoxic effects on AsPC-1. As shown in Figure 4 under 100 mM and greater than 25 mM may have recognisable dose-dependent effectiveness. These results indicate that the immunoliposomes must be prepared with a concentration of 100mM or more of '°B-compound for effective BNCT under our experimental conditions.
Effect of antibody density on the cytotoxicity Antibody on the liposomes plays a role in their carriage to target cells. In the next experiments, therefore, liposomes prepared with 250 mM "'B-compound were conjugated with various concentrations of anti-CEA, and the effects of these immunoliposomes on AsPC-1 cell growth were examined after thermal neutron irradiation. As shown in Figure 5 
Effect ofgamma-rays generated by thermal neutrons
There is a possibility that the inhibition of AsPC-l cells described above was actually due to the gamma-rays generated by thermal neutrons. As shown in Table I , cells irradiated with thermal neutrons were also irradiated with various doses of gamma-rays generated depending on the neutron dose. These doses of gamma-rays did not exert any inhibitory effect on AsPC-l cell growth. With 3.36 Gy gamma-rays, growth of AsPC-1 cell was suppressed weakly but significantly.
Failure of inhibition of tumour cell growth with soluble Cs2'°B,2H11SH In order to examine the effects of soluble '0B-compound (Cs2 'B H SH) on the proliferation of AsPC-cells, the cells were suspended in various concentrations of '°B-compound solution. After they were irradiated with 1 x 1012 to 5 x 1012 n cm-2 of thermal neutron, their growth was examined. As shown in Table II , the soluble '°B-compound did not significantly suppress the cell growth even at 2000 ppm (4 mM). If all of the liposomes prepared by using 250 mm of "'Bcompound were lysed to release '°B-compound into culture medium, it would make 312 ppm "'B-compound solution. Because the maximum '°B concentration entrapped in immunoliposomes was 623 ppm, and an equal volume of medium suspending target cells was added, the '0B-concentration in the medium must be reduced to half. These results may rule out the possibility that soluble '°B-compound in the medium emits alpha-particles by thermal neutron irradiation thereby injuring the cells.
Discussion
Antibody reactive to tumour cells is one of the most useful vehicles for ensuring selective accumulation of boron in tumours.
The effect of the 'OB-conjugated antibody on tumour cell growth in BNCT was reported first by Mizusawa et al. (1982 ), Goldenberg et al. (1984 . They conjugated 50 boron atoms directly to an antibody molecule, but the antibody did not work efficiently in BNCT. It was estimated that 109'OB atoms are required to destroy one tumour cell in BNCT (Alam et al., 1984) . When antibody directly conjugated with '°B-compound was used in BNCT, the quantity of 'OB atom delivered to a cell was proportional to the density of cell surface antigen molecules. According to Alam et al., an antibody has to be conjugated with 103 '0B atoms to destroy a tumour cell with 106 epitopes on its surface. One thousand, three hundred boron atoms were reported to be conjugated to a molecule of monoclonal antibody by using SPDP (Alam et al., 1985) .
A monoclonal antibody against alpha-foetoprotein was found to exert some cytotoxic effect on AH66 tumour cells in BNCT in vitro (Takahashi et al., 1987) . However, a heavy boronation of antibody has been shown to markedly reduce the antibody reactivity (Alam et al., 1985; Takahashi et al., 1987) and the numbers of epitope on the tumour cell surface have been estimated to be at most 106/cell (Tsukada et al., 1982; Barth et al., 1990) . These results indicate that monoclonal antibody directly conjugated with '0B-compound has limited application in BNCT.
A liposome is a vesicle which could entrap various materials, and a method of conjugating protein molecules on the surface by SPDP was developed . Therefore, it is possible for liposomes to carry a large amount of substance to the target cell surface, if the substance is entrapped in the liposome conjugated with monoclonal antibody specific against the cells. In fact, liposomebearing antibody against human P2-microglobulin was found to bind specifically to human cells but not to murine cells . Immunoliposomes containing actinomycin D were reported to exert cytotoxic effect in mammary carcinoma cells in an experimental model (Hashimoto et al., 1983) .
In experiments reported here, immunoliposomes suppressed tumour cell growth in vitro after thermal neutron irradiation.
Suppression was dependent upon the concentration of entrapped '0B-compound and also upon the density of anti-CEA conjugated with liposome. These results in in vitro experiments suggest that an immunoliposome containing '°B-compound could be applied in BNCT as an effective carrier of '0B-compound to target cells, and the evaluation of the system in in vivo experiments remains to be carried out. In the present experiment, gamma-rays generated by thermal neutron irradiation did not exert toxic effects on cell growth at less than 3.36 Gy. Therefore, 1 x 1012 or 2 x 1012 n cm-2 flux of thermal neutron may be recommended for BNCT, because inhibition of cell growth by concomitant gamma-rays was found to be negligible at these doses. The use of a more powerful atomic reactor may permit generation of more fluxes of thermal neutrons with less gamma-rays.
In the present experiments, immunoliposomes were found to be potential tools for BNCT, but problems remain to be solved before application to in vivo BNCT. First, lipid components of liposomes should be studied more extensively. In the present experiment, multilamellar liposomes were used, since small unilamellar ones composed of our lipid component were shown to be unstable in culture, although small unilamellar liposomes could be suitable for BNCT. If heatsensitive liposomes (Sullivan & Huang, 1985) were used for BNCT, treatment with hyperthermia could possibly be combined with BNCT to improve the efficiency of targeting of '0B to tumour cells. Secondly, the technique of conjugating antibody to liposome has to be improved, since F(ab')2 fragments seem to be better for targeting (Martin et al., 1981) , because depletion of the Fc fragment of the antibody molecule can obviate trapping of the molecule by Fc receptors on phagocytes or other cells.
However, the most important problem to resolve before clinical application of BNCT with immunoliposomes is how to carry the liposome specifically to the target tumour, or to promote penetration of blood vessels to reach tumour cells. It is conceivable that a complement component or some other substance could be conjugated to promote permeability of small blood vessels.
